REGENCELL BIOSCIENCE HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.56 USD | -10.61% |
|
+4.32% | -47.05% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
| 1st Jan change | Capi. | |
|---|---|---|
| -47.05% | 72.35M | |
| +17.96% | 47.02B | |
| +48.77% | 41.86B | |
| +1.17% | 41.76B | |
| -4.27% | 28.8B | |
| +11.42% | 26.05B | |
| -21.39% | 19.15B | |
| +4.86% | 12.55B | |
| +27.29% | 12.34B | |
| -3.50% | 11.82B |
- Stock Market
- Equities
- RGC Stock
- News Regencell Bioscience Holdings Limited
- Regencell Bioscience : Says IPO Raised $24.9 Million
